Therapeutic potential of N-acetylcysteine in age-related mitochondrial neurodegenerative diseases
- 1 April 2001
- journal article
- Published by Elsevier in Medical Hypotheses
- Vol. 56 (4) , 472-477
- https://doi.org/10.1054/mehy.2000.1194
Abstract
No abstract availableKeywords
This publication has 91 references indexed in Scilit:
- The antioxidant action of N-acetylcysteine: Its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acidPublished by Elsevier ,2003
- Oxidative Stress in Huntington's DiseaseBrain Pathology, 1999
- Oxidative damage and metabolic dysfunction in Huntington's disease: Selective vulnerability of the basal gangliaAnnals of Neurology, 1997
- Mitochondria, free radicals, and neurodegenerationCurrent Opinion in Neurobiology, 1996
- Behavioral pathology induced by repeated systemic injections of 3-nitropropionic acid mimics the motoric symptoms of Huntington's diseaseBrain Research, 1995
- Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates.Proceedings of the National Academy of Sciences, 1995
- A mitochondrial DNA deletion in normally aging and in Alzheimer brain tissueNeuroReport, 1993
- Electron transfer complex I defect in idiopathic dystoniaAnnals of Neurology, 1992
- Pharmacokinetics of N-acetylcysteine in manEuropean Journal of Clinical Pharmacology, 1986
- Regional Mitochondrial Respiratory Activity in Huntington's Disease BrainJournal of Neurochemistry, 1985